The results of induction chemotherapy with vinblastine, bleomycin, and cis-platinum II are reported. No survival advantage was seen when the entire treatment group was compared with an historical control group. Special attention is directed to the meaning of complete response and the potential treatment options and survival advantages of the complete responders subgroup.
Get full access to this article
View all access options for this article.
References
1.
. BrownAWJrBlomJ.ButlerWMGarcia GuerreroG.RichardsonMFHendersonRL: Combination chemotherapy with vinblastine, bleomycin, and cis-diamminedichloroplatinum (II) in squamous cell carcinoma of the head and neck. Cancer45: 2830–2835, 1980.
2.
. PerryDJCrainSMWeltzMDWilsonJPDavisRKWoolleyPVForastiereA.TaylorHGWeissRB: Phase II trial of mitoguazone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Cancer Treatment Rep67: 91–92, 1983.
. FreiE.IIIFreireichETGehanE.: Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-Mercaptopurine and methotrexate. Blood18: 431–454, 1961.
5.
. KishJ.DrelichmanA.WeaverA.JacobsJ.BergsmanK.Al SarrafM.: Cisplatinum and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Proceedings of the Eighteenth Annual Meeting of the American Society of Clinical Oncology1: 193, 1982.
6.
. HongWKShapshaySMBhutariR.CraftMLUcmakliA.YamaguchiKTVaughanCWStrongMS: Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion. Cancer44: 19–25, 1979.
7.
. DeVitaVTJrHellmanS.RosenbergSA: Cancer, principles and practice of oncology. Philadelphia, 1982, JB Lippincott Co, p 361.
